RHAMM/CD168-R3 peptide vaccination of HLA-A2+patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and multiple myeloma (MM) Meeting Abstract


Authors: Greiner, J.; Giannopoulos, K.; Li, L.; Liebisch, P.; Wendl, C.; Chen, J.; Ringhoffer, M.; Guillaume, P.; Ritter, G.; Doehner, H.; Schmitt, M.
Abstract Title: RHAMM/CD168-R3 peptide vaccination of HLA-A2+patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and multiple myeloma (MM)
Meeting Title: 47th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 106
Issue: 11 Pt. 1
Meeting Dates: 2005 Dec 10-13
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2005-11-01
Start Page: 780A
Language: English
ACCESSION: WOS:000233426005101
PROVIDER: wos
PUBMED: 16342400
DOI: 10.1182/blood.V106.11.2781.2781
Notes: --- - Meeting Abstract: 2781 - 47th Annual Meeting of the American-Society-of-Hematology - DEC 10-13, 2005 - Atlanta, GA - Part 1 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Gerd Ritter
    166 Ritter